Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Antithrombins%22&type=Subject&filter%5B%5D=collection%3ACTG
/vufind/Search/Results?lookfor=%22Antithrombins%22&type=Subject&filter%5B%5D=collection%3ACTG
Search /vufind/Search2/Results?lookfor=%22Antithrombins%22&type=Subject&filter%5B%5D=collection%3ACTG
PubPharm (47)
1
Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass : Phase 3, Double-blind, Placebo-controlled, Multicentre Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Belgian Antithrombin Deficiency Registry : Antithrombin Registry - Investigation of Phenotype-genotype Correlations in Patients With Inherited Antithrombin Deficiency
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
3
Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery : A Multicentre, Prospective, Open-label, Uncontrolled Phase 3 Study to Assess the Efficacy, Safety and Pharmacokinetics of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
4
Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate : A Phase II/III Pivotal Trial Evaluating the Safety, Pharmacokinetic Properties and Efficacy of a Plasma-Derived Anti-thrombin III Concentrate With Administration in Surgery, Pregnancy and Thromboembolic or Thrombotic Events
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
5
Antithrombin III in Infectious Disease Caused by COVID-19 : Antithrombin III (AT3) in Infectious Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)/ Coronavirus Disease of 2019 (COVID-19)
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
6
Patients with congenital antithrombin deficiency undergoing a pharmacokinetic assessment, surgery or giving birth are treated with Atenativ, an antithrombin concentrate : A multicentre, prospective, open-label, uncontrolled Phase III study to assess the efficacy, safety and pharmacokinetics of Atenativ in patients with congenital antithrombin deficiency undergoing surgery or delivery
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
Patients with congenital antithrombin deficiency undergoing a pharmacokinetic assessment, surgery or giving birth are treated with Atenativ, an antithrombin concentrate : A multicentre, prospective, open-label, uncontrolled Phase III study to assess the efficacy, safety and pharmacokinetics of Atenativ in patients with congenital antithrombin deficiency undergoing surgery or delivery
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery : A multicentre, prospective, open-label, uncontrolled Phase 3 study to assess the efficacy, safety and pharmacokinetics of Atenativ in patients with congenital antithrombin deficiency undergoing surgery or delivery
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery : A multicentre, prospective, open-label, uncontrolled Phase 3 study to assess the efficacy, safety and pharmacokinetics of Atenativ in patients with congenital antithrombin deficiency undergoing surgery or delivery
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery : A multicentre, prospective, open-label, uncontrolled Phase 3 study to assess the efficacy, safety and pharmacokinetics of Atenativ in patients with congenital antithrombin deficiency undergoing surgery or delivery
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
3
4
5
Nächster »
[5]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
47
Aufsätze
47
E-Artikel
47
E-Ressourcen
Zeitschriftentitel
32
WHO International Clinical Trials Registry Plat...
15
ClinicalTrials.gov
Thema
47
610
40
Study Type: Interventional
18
Phase: Phase 3
14
Antithrombin III Deficiency
14
Recruitment Status: Not yet recruiting
12
Medical Condition: Congenital antithrombin defi...
12
Recruitment Status: Authorised-recruitment may ...
10
Medical Condition: Hereditary Antithrombin Defi...
6
Recruitment Status: Completed
6
Study Type: Observational
5
Recruitment Status: Recruiting
3
Phase: Phase 2
2
Medical Condition: Congenital antithrombin defi...
2
Medical Condition: Early and severe preeclampsi...
2
Medical Condition: Hereditary Antithrombin AT D...
2
Medical Condition: Inclusion CriteriaPatient wi...
2
Medical Condition: The pregnancy women exhibit ...
2
Phase: Phase 4
2
Recruitment Status: Complete: follow-up complete
2
Recruitment Status: Terminated
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
26
2020-
21
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
47
Englisch
Haven't found what you're looking for?
Wird geladen...